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Abstract
Background: 18F-fluoro-2-deoxy-D-glucose (18F-FDG) accumulations are commonly seen in the neck-related mus-
cles of the surgical and non-surgical sides after surgery with neck dissection (ND) for oral cancers, which leads 
to radiologists having difficulty in diagnosing the lesions. To examine the alterations in 18F-FDG accumulation in 
neck-related muscles of patients after ND for oral cancer.
Material and Methods: 18F-FDG accumulations on positron emission tomography (PET)-computed tomography 
(CT) in neck-related muscles were retrospectively analyzed after surgical dissection of cervical lymph nodes in 
oral cancers.
Results: According to the extent of ND of cervical lymph nodes, the rate of patients with 18F-FDG-PET-positive ar-
eas increased in the trapezius, sternocleidomastoid, and posterior neck muscles of the surgical and/or non-surgical 
sides. In addition, SUVmax of 18F-FDG-PET-positive areas in the trapezius and sternocleidomastoid muscles were 
increased according to the extent of the ND.
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Conclusions: In evaluating 18F-FDG accumulations after ND for oral cancers, we should pay attention to the 18F-FDG 
distributions in neck-related muscles including the non-surgical side as false-positive findings.
Key words: 18F-FDG, PET-CT, oral cancers, muscles. 
Introduction
Surgical dissections are usually performed for patients 
with oral cancers and metastatic lymph nodes. Since the 
procedures induce anatomical and histological injuries 
of the tissues, precise evaluation for the recurrence of 
primary cancers and metastatic tumors of lymph nodes 
becomes very difficult using only computed tomogra-
phy (CT) and magnetic resonance imaging (MRI) (1,2). 
Therefore, positron emission tomography (PET)-CT us-
ing fluorine-18-labeled (18F) fluoro-2-deoxy-D-glucose 
(18F-FDG) should be used to evaluate recurrence of oral 
cancers and metastatic lymph nodes, and the clinical ap-
plications of this modality have expanded widely (1-6).
However, in our experience, 18F-FDG accumulations 
are commonly seen in the neck-related muscles of the 
surgical and non-surgical sides after surgery with neck 
dissection (ND) for oral cancers, which leads to radi-
ologists having difficulty in diagnosing the lesions. To 
the best of our knowledge, there have been no reports 
on 18F-FDG distribution in neck-related muscles of the 
oral and maxillofacial regions after surgery with ND 
for oral cancer.
In the present study, the alterations in the 18F-FDG dis-
tributions in neck-related muscles of the oral and maxil-
lofacial regions before and after surgery with ND for 
oral cancer were analyzed.
Material and Methods
Eighty consecutive patients (49 male, 31 female; mean ± 
standard deviation (SD) age 65.2±10.4 years, age range 
22-93 years) who had undergone surgery for oral can-
cers were evaluated at Kyushu Dental University hos-
pital between 2005 and 2014 (Table 1). CT, MRI, and 
18F-FDG-PET-CT were performed in all 80 patients. 
Informed consent was obtained before the respective 
imaging examinations. All procedures followed were in 
accordance with the ethical standards of the responsi-
ble committee on human experimentation and with the 
Helsinki Declaration. Approval of the present study was 
obtained from the institutional review board of Kyushu 
Dental University (No. 12-13).
Eighty patients were retrospectively divided into 4 
groups in the present study according to the extent of 
ND: Group 1 included 25 patients without ND; Group 2 
included 16 patients with supraomohyoid ND (SOHND) 
on the same side as the primary tumor, including 2 bi-
lateral cases; Group 3 included 24 patients with radical 
ND (RND) on the same side as the primary tumor; and 
Group 4 included 15 patients with RND on the same 
side as the primary tumor plus SOHND on the side con-
tralateral to the primary tumor. CT, MRI, and 18F-FDG-
PET-CT were performed at least six months after sur-
gery, because postoperative inflammation has generally 
almost completely disappeared by then. All imaging ac-
quisitions were done within one month. Patients whose 
CT, MRI, and 18F-FDG-PET-CT examinations were not 
all performed within one month were excluded. If all 
were to be performed, 18F-FDG-PET-CT could not be 
performed at the first visit to a doctor and/or within six 
months after the surgery. 
All patients fasted for at least 4 hours prior to intra-
venous administration of 0.1 mCi (3.7 MBq)/kg body 
weight of 18F-FDG. The examination by 18F-FDG was 
performed with a PET-CT inline system (Discover ST 
Elite, GE Medical Systems, Waukesha, WI, USA). One 
hour after 18F-FDG injection, each patient underwent a 
single integrated PET-CT examination. Patients were 
instructed not to chew or talk during the study. Prior 
to scanning, all patients had to remove objects such as 
removable dental bridgework and dentures from their 
mouth. The patients were positioned in the head-first, 
supine position. They were instructed to perform breath 
holding during the CT acquisition, which was done first 
from the head to the pelvic floor. For PET-CT imaging, 
the following parameters for the CT scan were used: 140 
kV, 60-160 mA (2D Auto mA), 0.6 seconds per tube ro-
tation, slice thickness of 4.25 mm, helical pitch of 1.5:1, 
22.50 mm/rotation table speed, 824.5-1096.5 mm cover-
age, and 22.8-30.0 seconds acquisition time. Immedi-
ately following the CT scan, a PET scan was acquired 
from the pelvic floor to the head. The PET camera had 
18 rings of 336 detectors and simultaneously produced 
35 4.34-mm-thick slices, along a 152-mm axial field of 
view (FOV), with 3-slice overlap at the borders of the 
FOV. The trans-axial resolution was 4.8 mm with full 
width at half-maximum at 1 cm radius from the center, 
and the sensitivity of the device was 1.3 cps/kBq with 
2D acquisition time of 2 minutes, resulting in a total 
scanning time of 18-24 minutes with each scan.
The CT data were back-projected to the workstation; the 
images were degraded from a 512 x 512 matrix to a 128 
x 128 matrix size to correspond with the PET images, 
and they were also forward-projected. The resulting 
sinograms were filtered with a 6.00-mm Post filter or 
a 4.30-mm Loop filter, exponentiated, and entered as 
attenuation correction factors into the PET image re-
Med Oral Patol Oral Cir Bucal. 2016 May 1;21 (3):e341-8.                                                                                                                                                          Alterations in 18F-FDG in neck muscles
e343
construction with two iterations and 21 subsets. On the 
other hand, all PET studies were iteratively reconstructed 
with no attenuation correction.
MR images were acquired using a 1.5-T full-body MR 
system (EXCELART VantageTM Powered by Atlas; 
Toshiba Co. Ltd., Tokyo, Japan) with a circular polar-
ized neck coil to visualize the maxilla and mandible 
level. Enhanced-CT was performed with an Aquilion™ 
machine (Toshiba Co. Ltd.) after the patient received an 
intravenous dose of 50 mL iohexol (300 mgI/mL; Om-
nipaque 300™, Daiichi Pharmaceutical Co. Ltd., Tokyo, 
Japan) at the start of scanning and an additional 50-mL 
intravenous infusion during the scanning to allow bet-
ter visualization of the vascular structures. Scanning 
was performed in the axial plane without angulation, 
in 5-mm-thick contiguous sections from the cavernous 
sinuses to the thoracic inlet.
The PET-CT, MR, and CT images were independently 
assessed by two expert radiologists (K.S. and K.H.).
All PET images were analyzed on a PC-based, digi-
tal viewing system (GE view, Dornstadt, Germany) to 
choose transverse slices for comparison and to adapt the 
level of the gray scale in the images. The extents of 18F-
FDG accumulations were judged by the standardized 
uptake value of the highest point within the regions of 
interest (SUVmax) for the representative neck-related 
muscles before the treatments and after surgery. The 
masseters, the anterior bellies of the digastric muscles, 
the geniohyoid, trapezius, sternocleidomastoid muscles, 
and posterior neck muscles together with the spinalis 
cervicis muscles, semispinalis cervicis muscles, semi-
spinalis capitis muscles, and splenius capitis muscles 
were investigated as the neck-related muscles. An SU-
Vmax cutoff of 1.5 was chosen as the presence or the 
absence of 18F-FDG accumulations, because it is com-
monly used as the no-color area in a 4-grade system, 
and the area could be easily judged (7). In addition, ra-
diologists generally pay no attention to such areas. In 
addition, the precise SUVmax of 18F-FDG for 18F-FDG-
PET-positive areas was measured in the respective mus-
cles mentioned above on PET-CT images.
All statistical analyses were performed using Stat 
View™ version 5.0 software (SAS Institute Inc., Cary, 
NC, USA). Differences in mean values among groups 
were analyzed using the Kruskal-Wallis test. Corre-
lations between two categories were analyzed using 
Spearman’s correlation coefficient. Results were con-
sidered significant if p<0.05.
Results
- Distribution of sites and SUVmax in primary sites of 
oral cancers
The distribution of the sites and of the SUVmax of the 
18F-FDG accumulations in the primary sites of oral can-
cers in the 80 patients are shown in table 1. The most 
common site was the tongue (50). The major pathologi-
Site of primary 
cancers (Numbers)
SUVmax of primary 
cancers (Mean±SD)
Age (Mean)
Male/Female 
(Numbers)
Pathological diagnosis (Numbers)
Tongue (50) 1.50-21.10 (8.91 ± 4.00) 35-86 (64.8) 33/17
Squamous Cell Carcinoma (47)
Spindle Cell Carcinoma (1)
Cystadenocarcinoma (1)
Malignant Melanoma (1)
Lower gingiva (11) 1.50-49.70 (15.70 ± 7.55) 51-81 (66.2) 5/6 Squamous Cell Carcinoma (11)
Upper gingiva (8) 3.17-22.00 (10.17 ± 6.28) 56-93 (75.4) 5/3
Squamous Cell Carcinoma (7)
Mucoepidermoid carcinoma (1)
Floor of mouth (3) 5.18-20.50 (12.29 ± 5.47) 39-67 (55.7) 3/0
Squamous Cell Carcinoma (2)
Adenoid Cystic Carcinoma (1)
Buccal mucosa (6) 3.08-7.50 (4.75 ± 1.30) 48-82 (65.8) 2/4 Squamous Cell Carcinoma (6)
Hard palate (2) 2.68-6.44 (4.56 ± 1.88) 22-58 (40.0) 1/1 Mucoepidermoid carcinoma (2)
Total (80) 1.50-49.70 (9.74 ± 5.01) 22-93 (65.8) 49/31
Squamous Cell Carcinoma (73)
Mucoepidermoid carcinoma (3)
Adenoid Cystic Carcinoma (1)
Spindle Cell Carcinoma (1)
Malignant Melanoma (1)
Cystadenocarcinoma (1)
Table 1. Data summary in 80 patients with oral cancers.
SUVmax: Standardized uptake value with the highest point of 18F-FDG
SD: Standard deviation.
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cal diagnosis was squamous cell carcinoma (SCC). The 
SUVmax of 18F-FDG in the primary lesions ranged 
from 1.50 to 49.70 (mean ± standard deviation (SD): 9.74 
± 5.00) (Table 1).
18F-FDG accumulations in neck-related muscles before 
surgery for patients with oral cancers
18F-FDG accumulations in neck-related muscles before 
surgery for patients with oral cancers are shown in ta-
ble 2. In all Groups, there were almost no patients with 
18F-FDG-positive areas in all examined muscles before 
surgery, and no significant differences were found in 
the rates of patients with 18F-FDG-positive areas among 
6 muscles in the 4 Groups (Table 2). Of course, no sig-
nificant differences were found in the rates of patients 
with 18F-FDG-positive areas among the 4 Groups in the 
respective 6 muscles (Table 2).
18F-FDG accumulations in neck-related muscles after 
minimally invasive surgery (Groups 1 and 2) for pa-
tients with oral cancers.
No significant differences were found in the rates of 
patients with 18F-FDG-PET-positive areas in the trape-
zius, sternocleidomastoid, and posterior neck muscles 
between before and after surgery in Groups 1 and 2 
(Tables 2,3). In Groups 1 and 2, no significant differ-
ences were found in the rates of patients with 18F-FDG-
positive areas among the 6 muscles after surgery (Fig. 
1 and Table 3).
Alterations in 18F-FDG accumulations in neck-related 
muscles after invasive surgery (Groups 3 and 4) for pa-
tients with oral cancers.
In Group 3, the rates of patients with 18F-FDG-PET-pos-
itive areas were significantly increased in the trapezius 
(p<0.004), sternocleidomastoid muscles of the non-
surgical side (p<0.0001), and posterior neck muscles 
of the non-surgical side (p<0.0001) between before and 
after surgery (Fig. 2 and Table 3), with similar results in 
Group 4 (Fig. 2 and Table 3). On the other hand, no sig-
nificant differences were found in the rates of patients 
with 18F-FDG-PET-positive areas in bilateral masseters, 
bilateral anterior bellies of the digastric muscles, and 
bilateral geniohyoid muscles between before and after 
surgery (Tables 2,3). There were no abnormal findings 
in bilateral trapezius muscles, sternocleidomastoid mus-
cles of the non-surgical side, and posterior neck muscles 
Muscles Groups
Numbers of patients with 18F-FDG 
accumulation into muscles (%)
SUVmax (Mean ± SD)
Trapeziuses
1
2
3
4
0/25 (0)
0/16 (0)
0/24 (0)
0/15 (0)
0.67-1.31 (0.90 ± 0.12)
0.61-1.05 (0.81 ± 0.12)
0.58-1.38 (0.88 ± 0.16)
0.46-0.99 (0.77 ± 0.13)
Sternocleidomastoid
1
2
3
4
0/25 (0)
0/16 (0)
0/24 (0)
0/15 (0)
0.78-1.49 (1.17 ± 0.12)
0.93-1.41 (1.13 ± 0.10)
0.83-1.43 (1.09 ± 0.13)
0.90-1.45 (1.11 ± 0.13)
Posterior necks
1
2
3
4
1/25 (4.0)
1/16 (6.3)
1/24 (4.2)
1/15 (6.7)
0.90-1.54 (1.18 ± 0.15)
0.93±1.91 (1.26 ± 0.19)
0.90±1.59 (1.16 ± 0.18)
0.91-2.49 (1.24 ± 0.21)
Masetter
1
2
3
4
1/25 (4.0)
1/16 (6.3)
0/24 (0)
1/15 (6.7)
0.81-1.52 (1.12 ± 0.15)
0.75-1.52 (1.14 ± 0.17)
0.52-1.39 (1.11 ± 0.13)
0.75-1.58 (1.07 ± 0.10)
Anterior belly of 
digastric
1
2
3
4
0/25 (0)
0/16 (0)
1/24 (4.2)
0/15 (0)
0.69-1.44 (1.06 ± 0.14)
0.71±1.42 (1.00 ± 0.17)
0.74-1.61 (1.10 ± 0.16)
0.68-1.47 (1.08 ± 0.24)
Geniohyoid
1
2
3
4
0/25 (0)
1/16 (6.3)
1/24 (4.2)
1/15 (6.7)
1.17-1.43 (1.08 ± 0.15)
1.15-1.51 (1.09 ± 0.12)
0.98-1.56 (1.12 ± 0.14)
1.00-1.50 (1.18 ± 0.14)
Table 2. 18F-FDG accumulations into neck-related muscles before surgeries for patients with oral cancers.
18F-FDG: Fluorine-18-labeled (18F) fluoro-2-deoxy-D-glucose; SUVmax: Standardized uptake value with the highest point of 18F-FDG; 
SD: Standard deviation ; Posterior neck muscles (spinalis cervicis muscle, semispinalis cervicis muscle, semispinalis capitis muscle, 
splenius capitis muscle.
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of the non-surgical side in patients with 18F-FDG-PET-
positive areas on CT and MRI (Fig. 2).
Correlations between the alterations in 18F-FDG accu-
mulations in neck-related muscles after surgery and the 
extent of dissection in patients with oral cancers
A moderate correlation was found between the rates of 
patients with 18F-FDG-PET-positive areas in the trapezi-
us muscles and the extent of surgical dissection in the 4 
Groups (r=0.40, p<0.0001), with moderate correlations 
for the sternocleidomastoid muscles (r=0.442, p<0.0001) 
and the posterior neck muscles (r=0.445, p<0.0001). 
Moreover, a strong correlation was found between the 
rates of patients with 18F-FDG-PET-positive areas in at 
least one of the trapezius, sternocleidomastoid, and pos-
terior neck muscles and the extent of surgical dissection 
in the 4 Groups (r=0.665, p<0.01) (Table 4).
The SUVmax values of 18F-FDG-PET-positive areas in 
the trapezius, sternocleidomastoid, and posterior neck 
muscles after surgery ranged from 1.50 to 4.04  (Table 
3). In addition, a weak correlation was found between 
the SUVmax of 18F-FDG-PET-positive areas in the tra-
pezius muscles and the extent of surgical dissection in 
the 4 Groups (r=0.32, p<0.002), as well as a weak cor-
relation in the sternocleidomastoid muscles (r=0.258, 
p<0.011).
Discussion
The most interesting result of the present study was that 
18F-FDG-PET-positive areas appeared in the trapezius, 
sternocleidomastoid, and posterior neck muscles of the 
surgical and non-surgical sides after RND for oral can-
cers despite no abnormal findings, including hypertro-
phy, on CT and MRI. In addition, the rates of patients 
with 18F-FDG-PET-positive areas increased depending 
on the extent of the dissection for cervical lymph nodes. 
There have been no previous reports on 18F-FDG dis-
tribution in neck-related muscles of the oral and maxil-
lofacial regions after surgery with ND for oral cancer. 
It has been reported that hypertrophy of the levator 
scapulae muscles, trapezius muscles, and sternocleido-
Muscles Groups
Numbers of patients with 18F-FDG 
accumulation into muscles (%)
SUVmax (Mean±SD)
Trapeziuses
1
2
3
4
0/25 (0)
1/16 (6.3)
5/24 (20.8)
6/15 (40.0)
0.69-1.29 (0.94 ± 0.15)
0.68-1.59 (0.94 ± 0.15)
0.71-2.57 (1.21 ± 0.38)
0.70-3.14 (1.49 ± 0.64)
Sternocleidomastoid
1
2
3
4
1/25 (4.0)
0/16 (0)
10/24 (41.7)
6/15 (40.0)
0.86-1.64 (1.16 ± 0.12)
1.01-1.41 (1.20 ± 0.10)
0.92-2.71 (1.56 ± 0.58)
0.84-3.50 (1.94 ± 0.88)
Posterior necks
1
2
3
4
0/25 (0)
1/16 (6.3)
9/24 (38.0)
6/15 (40.0)
0.99-1.48 (1.21 ± 0.10)
0.96±1.54 (1.18 ± 0.14)
0.89±4.04 (1.65 ± 0.64)
0.90-3.10 (1.63 ± 0.58)
Masetter
1
2
3
4
0/25 (0)
1/16 (6.3)
1/24 (4.2)
1/15 (6.7)
0.79-1.39 (1.14 ± 0.15)
0.70-1.58 (1.17 ± 0.18)
0.96-1.60 (1.25 ± 0.15)
0.84-1.61 (1.17 ± 0.15)
Anterior belly of 
digastric
1
2
3
4
1/25 (4.0)
0/16 (0)
0/24 (0)
0/15 (0)
0.72-1.69 (1.03 ± 0.17)
0.78±1.38 (1.05 ± 0.16)
0.82-1.47 (1.13 ± 0.16)
0.64-1.19 (1.06 ± 0.14)
Geniohyoid
1
2
3
4
1/25 (4.0)
0/16 (0)
0/24 (0)
1/15 (6.7)
0.73-2.01 (1.23 ± 0.17)
0.93-1.33 (1.12 ± 0.11)
0.94-1.47 (1.25 ± 0.12)
1.05-1.51 (1.25 ± 0.12)
18F-FDG: Fluorine-18-labeled (18F) fluoro-2-deoxy-D-glucose.
Table 3. 18F-FDG accumulations into neck-related muscles after surgeries for patients with oral cancers.
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Fig. 2. 18F-FDG-PET-CT, CT, and MRI examinations of a 51-year-old man 
18 months after surgery with ND for SCC of the left side of the mandibular 
gingiva (A, D, G); of a 78-year-old man 9 months after surgery with ND for 
SCC on the right side of the tongue (B, E, H); and of a 61-year-old man 35 
months after surgery with ND for SCC on the right side of the tongue (C, F, 
I). 18F-FDG-PET-CT demonstrates increased uptake in the trapezius (SUV-
max 2.1) (arrows) (A), sternocleidomastoid (SUVmax 1.9) (arrows) (B), and 
posterior neck muscles (SUVmax 2.2) (arrows) (C). STIR shows no signal 
changes of the trapezius (arrows) (D), sternocleidomastoid (arrows) (E), 
and posterior neck muscles (arrows) (F) in 18F-FDG-PET-positive areas. 
CT with a soft tissue window shows no density changes of the trapezius 
(arrows) (G), sternocleidomastoid (arrows) (H), and posterior neck muscles 
(arrows) (I) in 18F-FDG-PET-positive areas.
Fig. 1. 18F-FDG-PET-CT, CT, and MRI examinations of a 61-year-old woman 8 
months after surgery without ND for SCC of the right side of the gingiva.
18F-FDG-PET-CT demonstrates no increased uptake in the trapezius (arrows) 
(A), sternocleidomastoid (arrows), and posterior neck muscles (arrowheads) 
(B). STIR shows no signal changes of the trapezius (arrows), (C) sternocleido-
mastoid (arrows), and posterior neck muscles (arrowheads) (D). CT with a soft 
tissue window shows no density changes of the trapezius (arrows) (E), sterno-
cleidomastoid (arrows), and posterior neck muscles (arrowheads) (F).
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mastoid muscles occurred on the non-surgical side after 
RND of the neck using electromyography in previous 
reports (8-11). In addition, it was noted that radiologists 
should pay attention to the differential diagnosis be-
tween tumors and hyperplasia of the muscles mentioned 
above on CT and MRI examinations (12). Based on the 
present results, however, it is important to understand 
that possible increases of 18F-FDG accumulations in the 
muscles mentioned above are unrelated to hypertrophy 
when they show 18F-FDG accumulation after RND.
Moreover, SUVmax values of 18F-FDG-PET-positive 
areas of the trapezius, sternocleidomastoid, and pos-
terior neck muscles after surgery were relatively low, 
but ranged from 1.5 to 4.04. In previous studies, as well 
as in the present study (1.50 to 49.70), the SUVmax of 
carcinomas in the oral cavity ranged from 1.38 to 15.9; 
there is some overlap in the SUVmax caused by dental 
inflammation and that caused by carcinomas (7,13-16). 
It is important to perform an appropriate differential 
diagnosis between normal variations after surgery and 
malignant tumors on CT and/or MRI, in addition to 
paying attention to alterations in the distribution of 18F-
FDG accumulations. In particular, it is important to pay 
attention to differentiating between the two, since SUV-
max values of 18F-FDG accumulations tend to increase 
with extensive surgical methods such as RND.
It is difficult to explain the present results, since this 
was the first study of 18F-FDG distribution after surgery 
for oral and maxillofacial cancers. One of the possible 
explanations for these findings is that the 18F-FDG-PET-
positive areas of the trapezius, sternocleidomastoid 
muscles, and posterior neck muscles may be related to 
the muscles’ hypertonia and the compensation that oc-
curs with neck exercise (8-11). The other is that stiff-
neck after surgeries could be related to muscles with 
18F-FDG-PET-positive areas. Further study is needed to 
elucidate the reasons behind these results.
One possible limitation of the present study is that the 
sample size was small. The variables of age, race, and 
sex could not be studied in this study sample. In addi-
tion, the analyzed data did not include the precise dis-
section areas and the methods and extent of reconstruc-
tion. Therefore, the present results should be considered 
with care. However, we should pay attention to altera-
Groups
Numbers of patients with 18F-FDG accu-
mulation into remained muscles (%)
1 1/25 (4.0)
2 2/16 (12.5)
3 18/24 (75.0)
4 12/15 (80.0)
Table 4. Relationships between the rates of patients with 18F-FDG-
PET-positive areas and the extent of surgical methods.
(N=80); 18F-FDG: Fluorine-18 labeled (18F) fluoro-2-deoxy-D-glu-
cose.
tions in the distributions in adjacent remaining muscles, 
including non-surgical sides, when evaluating 18F-FDG 
accumulations after surgery for oral cancer.
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